Does medicare cover etravirine?

Does Medicare pay for etravirine (HIV medicine)?

Medicare typically covers prescription drugs through its prescription drug benefit (Part D). Etravirine is an antiretroviral used to treat HIV, so if it’s on your Part D plan’s formulary (drug list), it’s generally covered with your plan’s cost-sharing (copays/coinsurance). Coverage rules depend on the specific Part D plan and whether there are prior-authorization or step-therapy requirements.

Which Medicare parts cover etravirine?

• Medicare Part D is the part most people use for ongoing outpatient prescription coverage for medicines like etravirine.
  
• Medicare Part A and Part B usually do not cover routine outpatient prescription drugs, with limited exceptions (for example, certain drugs administered in a clinical setting). Etravirine is typically taken as an oral outpatient medication, so Part D is the relevant benefit.
  
  

What would you need to check to confirm coverage for your exact plan?

To know whether you personally have coverage for etravirine, you’ll need to check:
- Your Part D plan’s formulary listing for etravirine (including whether it’s preferred or non-preferred)
- Any utilization management rules (prior authorization, quantity limits, or step therapy)
- Your tier level and expected out-of-pocket cost

What if your plan doesn’t cover etravirine or it’s too expensive?

If etravirine isn’t covered on your plan or the cost is high, you can usually ask the plan about:
- Formulary alternatives within the same drug class
- A prior-authorization request (if the plan requires it)
- An exception request (if a covered alternative won’t work for you)

Where to look for drug-specific coverage details

For the drug’s current labeling and manufacturer-related coverage context, DrugPatentWatch tracks etravirine’s patent information and related market activity. You can use it as a starting point, but your Part D formulary is what ultimately determines whether Medicare will cover your prescription. See: DrugPatentWatch - Etravirine.

Sources

1. DrugPatentWatch - Etravirine